Abstract:Background Coronary microvascular dysfunction (CMD) after ST-Elevation Myocardial Infarction (STEMI) is associated with persistent symptoms and poor outcomes. Microvascular Resistance Reserve (MRR) is an innovative metric for evaluating coronary microvasculature that is unaffected by epicardial stenoses or the hemodynamic impact of vasodilators. While MRR's prognostic ability is recognized in chronic coronary syndrome, its application in ACS remains unestablished. Purpose We sought to investigate the prognostic value of MRR in STEMI patients. Methods This is a prospective study of 210 STEMI patients with multivessel disease who had undergone successful primary percutaneous coronary intervention (PCI). At 3 months follow-up, they returned for complete revascularization and coronary physiology evaluations, including coronary flow reserve (CFR), fractional flow reserve (FFR), and index of microcirculatory resistance (IMR), using bolus thermodilution. MRR was calculated using the formula: MRR = (CFR/FFR) × (Pa rest/Pa hyper), where Pa rest and Pa hyper represent resting and hyperemic aortic pressure, respectively1. We utilized an MRR cutoff of 3.0 based on Boerhour et al. The association between MRR and major adverse cerebrocardiovascular events (MACCE) at 12-month follow-up, defined as the composite of stroke, revascularization, myocardial infarction (MI), heart failure hospitalization, and death, was investigated. Results The median age was 65 years, and 40.48% were female. At a 3-month follow-up, 27% (56 patients) exhibited MRR <3.0, who were predominantly female (62.50% vs 32.47%, p<0.001) with a higher incidence of diabetes (39.29% vs 18.83%, p = 0.004). No significant differences were observed in age, body mass index, or STEMI location (anterior or inferior) when comparing between MRR groups. The MACCE-free survival at 12 months was significantly lower in patients with an MRR < 3.0 (48.2%) compared to those with an MRR ≥ 3.0 (11.0%; log-rank p < 0.001, Fig1A). The MRR < 3.0 group showed higher rates of ischemic stroke (8.93% vs. 1.30%, p = 0.022) and hospitalization for heart failure (21.43% vs. 2.60%, p < 0.001), while the incidence of nonfatal myocardial infarction (MI) and cardiovascular death were similar between the two MRR groups (Figu1B). In multivariable Cox regression analysis, MRR was an independent predictor for 12-month MACCE (Hazard Ratio 0.45 per unit increase, 95% Confidence Interval 0.31-0.67, p<0.001). The areas under the receiver operating characteristic curves for predicting 12-month MACCE using FFR, CFR, IMR, and MRR yielded values of 0.609, 0.762, 0.781, and 0.743, respectively (Fig2). The prognostic performances of CFR, IMR, and MRR were similar and superior to that of FFR. Conclusion This study establishes the novel parameter MRR as a superior prognostic indicator in STEMI patients compared to FFR, and on par with CFR and IMR. MRR is a reliable predictor of MACCE, and various clinical incidents post-STEMI.

Microvascular resistance reserve: Impact of autoregulation on its conceptual framework and practical implementation

Effect of Microcirculatory Resistance on Coronary Blood Flow and Instantaneous Wave-Free Ratio: A Computational Study.

Index of Microcirculatory Resistance: State-of-the-art and Potential Applications in Computational Simulation of Coronary Artery Disease

The Influence of Epicardial Resistance on Microvascular Resistance Reserve

Microvascular resistance reserve: diagnostic and prognostic performance in the ILIAS registry

The interplay between coronary microvascular resistance, arterial reservoir function and coronary flow reserve: unravelling the significance of high microvascular resistance

Microvascular resistance reserve: impact on health status and myocardial perfusion after revascularization in chronic coronary syndrome

The impact of the microvascular resistance on the measures of stenosis severity

Monitoring of cerebral blood flow autoregulation: physiologic basis, measurement, and clinical implications

Integration of Clinical, Biological, and Computational Perspectives to Support Cerebral Autoregulatory Informed Clinical Decision Making Decomposing Cerebral Autoregulation using Mechanistic Timescales to Support Clinical Decision-Making

Depth-Dependent Contributions of Various Vascular Zones to Cerebral Autoregulation and Functional; Hyperemia: An In-Silico Analysis

Advancing prognostic insights in STEMI patients through microvascular resistance reserve evaluation

Prognostic Value of Microvascular Resistance Reserve Measured Immediately After PCI in Stable Coronary Artery Disease

Factors Associated with Impaired Resistive Reserve Ratio and Microvascular Resistance Reserve

The pressure-derived microvascular resistance reserve and its correlation to Doppler MRR measurement—a proof of concept study

In Vivo Validation of a Novel Computational Approach to Assess Microcirculatory Resistance Based on a Single Angiographic View

Impact of sex on the assessment of the microvascular resistance reserve

Impact of microvascular resistance reserve on post-STEMI cardiac remodelling and diastolic function

Prognostic Implications of Microvascular Resistance Reserve in Symptomatic Patients With Intermediate Coronary Stenosis

Abstract 51: Impact of Cerebral Autoregulation on the Relationship Between Blood Pressure Variability and Functional Outcome Following Endovascular Thrombectomy

Cerebral hemodynamics in acute stroke: pathophysiology and clinical implications